Shareholders Equity: The sum of preferred and common equity items.
Dogwood Therapeutics, Inc (DWTX) had Shareholders Equity of $74.90M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-35.51M |
|
-- |
|
-- |
|
$27.97M |
|
$-27.97M |
|
$-6.07M |
|
$-34.04M |
|
$-34.03M |
|
$-34.26M |
|
$-34.26M |
|
$-34.26M |
|
$-34.25M |
|
$-27.97M |
|
$-27.91M |
|
4.98M |
|
4.98M |
|
$-7.13 |
|
$-7.13 |
|
| Balance Sheet Financials | |
$8.43M |
|
$0.01M |
|
$81.74M |
|
$90.17M |
|
$3.06M |
|
-- |
|
$12.22M |
|
$15.27M |
|
$74.90M |
|
$-6.49M |
|
|
Shareholders Equity |
$74.90M |
29.74M |
|
| Cash Flow Statement Financials | |
$-15.62M |
|
-- |
|
$7.28M |
|
$14.85M |
|
$6.52M |
|
$-8.32M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-45.74% |
|
527.91% |
|
-37.99% |
|
-45.74% |
|
$2.52 |
|
$-3.14 |
|
$-3.14 |
|